Met Life Investment Management, LLC Edgewise Therapeutics, Inc. Transaction History
Met Life Investment Management, LLC
- $20.1 Billion
- Q3 2025
A detailed history of Met Life Investment Management, LLC transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 43,883 shares of EWTX stock, worth $998,338. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43,883
Previous 43,883
-0.0%
Holding current value
$998,338
Previous $575,000
23.65%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding EWTX
# of Institutions
186Shares Held
112MCall Options Held
188KPut Options Held
121K-
Orbimed Advisors LLC San Diego, CA15.5MShares$353 Million8.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA10.4MShares$237 Million2.9% of portfolio
-
Baker Bros. Advisors LP New York, NY7.31MShares$166 Million0.97% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY6.17MShares$140 Million3.22% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$137 Million0.0% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.44B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...